Hippo Q2 Earnings: Net Income Jumps to $10M, Guidance Raised on 61% Premium Growth
HIPO sits 24% above its 52-week low of $24.08.
Summary
Hippo reported Q2 2026 net income of $10.1M, up from $1.3M a year ago, on 61% gross written premium growth. Full-year guidance was raised, with adjusted net income now expected up to $70M.
Key Events · Earnings and Guidance · HIPO
-
Net Income Surges to $10.1M
Q2 2026 net income attributable to Hippo was $10.1 million, or $0.38 per diluted share, compared to $1.3 million in Q2 2025. Adjusted net income was $21.0 million, or $0.79 per diluted share.
-
Gross Written Premium Up 61%
Gross written premium reached $482 million, driven by 177% growth in Casualty and 65% growth in Commercial Multi-Peril. The company continues to diversify away from Homeowners, which now represents only 22% of GWP.
-
Combined Ratio Improves to 95.8%
The combined ratio improved 4 percentage points year-over-year to 95.8%, reflecting underwriting profitability. The expense ratio fell to 45.4% from 53.1%, driven by operating leverage and expense discipline.
-
Full-Year Guidance Raised
Management raised 2026 guidance: gross written premium now expected at $1.65-$1.7 billion (up from $1.45-$1.525 billion), adjusted net income at $62-$70 million (up from $48-$56 million), and combined ratio improved to 99%-101%.
Analysis · HIPO · Finance
A breakout quarter underscores the company's accelerating turnaround. Net income surged to $10.1 million from $1.3 million a year ago, while gross written premium jumped 61% to $482 million, fueled by explosive growth in Casualty and Commercial Multi-Peril lines. The combined ratio improved to 95.8%, signaling clear underwriting profitability. Reflecting this momentum, management raised full-year guidance across the board—now projecting over $1.65 billion in gross written premium and up to $70 million in adjusted net income. These results validate the pivot to a diversified, technology-native insurance platform and suggest the recovery is gaining real traction.
At the time of this filing, HIPO was trading at $29.83 on NYSE in the Finance sector, with a market capitalization of approximately $776.7M. The 52-week trading range was $24.08 to $38.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.